CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime].

CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Abstract Text:

Michael Zhuo Wang,Janelle Y Saulter,Etsuko Usuki,Yen-Ling Cheung,Michael Hall,Arlene S Bridges,Greg Loewen,Oliver T Parkinson,Chad E Stephens,James L Allen,Darryl C Zeldin,David W Boykin,Richard R Tidwell,Andrew Parkinson,Mary F Paine,James Edwin Hall,

DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime] is biotransformed to the potent antiparasitic diamidine DB75 [2,5-bis(4-amidinophenyl) furan] by sequential oxidative O-demethylation and reductive N-dehydroxylation reactions. Previous work demonstrated that the N-dehydroxylation reactions are catalyzed by cytochrome b5/NADH-cytochrome b5 reductase. Enzymes responsible for catalyzing the DB289 O-demethylation pathway have not been identified. We report an in vitro metabolism study to characterize enzymes in human liver microsomes (HLMs) that catalyze the initial O-demethylation of DB289 (M1 formation). Potent inhibition by 1-aminobenzotriazole confirmed that M1 formation is catalyzed by P450 enzymes. M1 formation by HLMs was NADPH-dependent, with a Km and Vmax of 0.5 microM and 3.8 nmol/min/mg protein, respectively. Initial screening showed that recombinant CYP1A1, CYP1A2, and CYP1B1 were efficient catalysts of M1 formation. However, none of these three enzymes was responsible for M1 formation by HLMs. Further screening showed that recombinant CYP2J2, CYP4F2, and CYP4F3B could also catalyze M1 formation. An antibody against CYP4F2, which inhibited both CYP4F2 and CYP4F3B, inhibited 91% of M1 formation by HLMs. Two inhibitors of P450-mediated arachidonic acid metabolism, HET0016 (N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine) and 17-octadecynoic acid, effectively inhibited M1 formation by HLMs. Inhibition studies with ebastine and antibodies against CYP2J2 suggested that CYP2J2 was not involved in M1 formation by HLMs. Additionally, ketoconazole preferentially inhibited CYP4F2, but not CYP4F3B, and partially inhibited M1 formation by HLMs. We conclude that CYP4F enzymes (e.g., CYP4F2, CYP4F3B) are the major enzymes responsible for M1 formation by HLMs. These findings indicate that, in human liver, members of the CYP4F subfamily biotransform not only endogenous compounds but also xenobiotics.

CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Publishing Authors By Initials

MZ Wang,JY Saulter,E Usuki,YL Cheung,M Hall,AS Bridges,G Loewen,OT Parkinson,CE Stephens,JL Allen,DC Zeldin,DW Boykin,RR Tidwell,A Parkinson,MF Paine,JE Hall,

For similar pharmaceutical preparations: prodrugs research abstracts see: pharmaceutical preparations: prodrugs research

PUBMED ID PMID:

MEDLINE DATE:

CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Drug metabolism and disposition: the biological fa

VOLUME: 34

Page Numbers: 1985-94

Journal Abbreviation: Drug Metab. Dispos.

ISSN: 0090-9556

DAY: 22

MONTH: 09

YEAR: 2006

CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9421550

CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Keywords Mesh Terms:

KEYWORDS: Prodrugs

MESH TERMS: metabolism

Chemical & Substance for Abstract: CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Information

Substance Name: Cytochrome P-450 Enzyme System

Registry Number: 9035-51-2

Grant and Affiliation Information for CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime].

AFFILIATION: Division of Molecular Pharmaceutics, School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Country: United States

AGENCY: United States NIEHS

GRANT: Z01 ES025034-13

ACRONYM: ES

MEDLINETA: Drug Metab Dispos

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 2,5-bis4-amidinophenylfuran-bis-O-methylamidoxime Related Publications

• A comparison of Ki67 immunostaining and nucleolar organiser region staining in non-Hodgkin's lymphoma. P. A. Hall, J. Crocker, A. Watts, A. G. Stansfeld. Histopathology 1988; 12; 373-381 &.
• A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases.
• A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways.
• A summary of recommendations for the management of opioid dependence: the quality assurance in the treatment of drug dependence project.
• AQP0-LTR of the Cat Fr mouse alters water permeability and calcium regulation of wild type AQP0.
• Activation of G1 progression, JNK mitogen-activated protein kinase, and actin filament assembly by the exchange factor FGD1.
• Activin and bone morphogenetic proteins induce calcitonin gene-related peptide in embryonic sensory neurons in vitro.
• Editorial.
• Effect of cartilage oligomeric matrix protein on mesenchymal chondrogenesis in vitro.
• Effect of nutrition on the LH response to calf removal and GnRH.
• Efficient chondrogenic differentiation of mesenchymal cells in micromass culture by retroviral gene transfer of BMP-2.
• Gene expression profiling following BMP-2 induction of mesenchymal chondrogenesis in vitro.
• In-situ hydration studies using multi-angle energy-dispersive diffraction.
• International studies in dementia with particular emphasis on populations of African origin.
• Investigations of the incidence of bovine trichomoniasis in nevada and of the efficacy of immunizing cattle with vaccines containing Tritrichomonas foetus.
• Is ultrasound useful for evaluating paediatric inflammatory neck masses?
• Laparoscopic transfer of ovine and cervine embryos using the transpic technique.
• Nonword repetition skills in young children who do and do not stutter.
• Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
• Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade.
• Rac/Cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin through phosphorylation at serine 16.
• Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes.
• Spontaneous formation of annular structures observed in molecular dynamics simulations of polyglutamine peptides.
• Systems approaches to biological rhythms in Drosophila.
• The effectiveness of methadone maintenance treatment: an overview.
• The use of derivative and least-squares methods to analyse a polypharmaceutical product by UV spectrophotometry.
• Validation analysis of informant's ratings of cognitive function in African Americans and Nigerians.
• Viral Load and Neuropsychological Functioning in HIV Seropositive Individuals:A Preliminary Descriptive Study.
• [In Process Citation]
• [In Process Citation]